It has been reported that S100A9 probably plays a key role in inflammation-related breast cancers and induces the expression of pro-inflammatory cytokines (IL-6, IL-8, and IL-1β), thus, its expression level can be used to diagnose breast cancer (112, 113). Here, CXCL8 is linked to breast carcinoma.